Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-25-009073

Options or other derivatives

  • EVP, CHIEF LEGAL OFFICER, SEC acquired 132,351 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC 2025-03-24 Grant or award · Stock Option (Right to Buy) +102,289 102,289 D
Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC 2025-03-24 Grant or award · Restricted Stock Units +30,062 30,062 D
Loading xslF345X05/form4-03272025_120324.xml…